Patents by Inventor Christopher SANTINI

Christopher SANTINI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for classifying DLBCL
    Patent number: 11124840
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: September 21, 2021
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • Methods and Compositions for Classifying DLBCL
    Publication number: 20190144947
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Application
    Filed: May 11, 2017
    Publication date: May 16, 2019
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • Methods and compositions for classifying DLBCL
    Patent number: 9963748
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: May 8, 2018
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • METHODS AND COMPOSITIONS FOR CLASSIFYING DLBCL
    Publication number: 20170327897
    Abstract: Provided herein are methods and compositions to classify DLBCL subtypes using quantitative RT-PCR.
    Type: Application
    Filed: May 11, 2017
    Publication date: November 16, 2017
    Inventors: Rajiv Dua, Marcel Fontecha, Yan Li, Wei-min Liu, Christopher Santini, Lori Steiner, Yu Chuan Tai
  • MULTIPLEX ASSAYS FOR HORMONAL AND GROWTH FACTOR RECEPTORS, AND USES THEREOF
    Publication number: 20090203015
    Abstract: The present invention provides compositions and methods for simultaneously detecting mRNA expression levels of hormonal receptors, particularly both estrogen receptor (ER) and progesterone receptor (PR), optionally in combination with growth factor receptors, particularly epidermal growth factor receptor ERBB2 (Her-2), and further optionally in combination with control genes, such as the housekeeping genes NUP214 and/or PPIG. Exemplary embodiments of the invention are useful for determining hormonal receptor and/or growth factor receptor status, particular both ER and PR status and optionally also ERBB2 status, such as for assessing or treating breast cancer.
    Type: Application
    Filed: January 19, 2009
    Publication date: August 13, 2009
    Applicant: CELERA CORPORATION
    Inventors: Sheng-Yung CHANG, Christopher SANTINI, Ayuko IVERSON, Thomas VESS